Zack Cheng is the founder of Zion Pharma. Zion Pharma has raised $69M in total funding. Latest round: Series B. Backed by Qiming Venture Partners.
Zack Cheng is the Chairman, CEO, and Founder of Zion Pharma, a private, clinical-stage biotech company focused on developing novel small-molecule anti-tumor agents. Zion Pharma entered a global development and commercialization agreement with Roche for ZN-A-1041.
Full founder directory · Investor directory · Company funding database · Fundraising library